Skip to main content
OpenTrials
Completed

NCT Number: NCT04389294

HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists

The goal of this study is to understand the infectious exposure of SARS-coronavirus 2 (SARS-CoV2) among surgeons and anesthesiologists and to correlate this status with self-reported indices of COVID-19 illness.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital for Special Surgery

New York, 10021, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Accredited to practice at HSS
  • All anesthesiology and surgery faculty
  • All anesthesia and orthopedic surgery fellows
  • All orthopedic surgery residents

Exclusion criteria

  • Refusal to participate in either of the interventions at either of the timepoints of interest

Treatment and study plan

SARS-CoV2 serum antibody testing

Diagnostic Test

Participants will have SARS-CoV2 serum antibody testing performed twice within 4 months of each other.

Primary outcomes

  1. Number of Participants With SARS-CoV-2 IgG Antibodies

    Time frame: Serology Test #1 (Study Enrollment) and Test #2 (3 months apart)

    Prevalence of SARS-CoV-2 IgG antibodies by serology testing in participants at the time of study enrollment or 3 months later

Secondary outcomes

  1. Differences in Sex Between IgG Antibody-positive vs. Negative Participants

    Time frame: Survey completed before or on day of serology testing asking about information from January 1, 2020 to May 5, 2020

    Secondary outcomes included differences in the survey responses between IgG antibody-positive and -negative participants. These included demographics such as sex.

  2. Number of Asymptomatic Participants With Positive Antibody Serology

    Time frame: Serology Test #1 (Study Enrollment) and Serology Test #2 (3 months apart)

    Number of asymptomatic participants with positive antibody serology at either the study enrollment timepoint or 3 month timepoint

  3. Percentage of Antibody-positive Participants Who Subsequently Develop COVID-19

    Time frame: Serology Test #1 (Study Enrollment) and Serology Test #2 (3 months apart)

    Percentage of antibody-positive participants who subsequently develop COVID-19 at either the study enrollment timepoint or the 3 months time point

  4. Differences in Race Between IgG Antibody-positive vs. Negative Participants

    Time frame: Survey completed before or on day of serology testing asking about information from January 1, 2020 to May 5, 2020

    Secondary outcomes included differences in the survey responses between IgG antibody-positive and -negative participants. These included demographics such as race.

  5. Differences in Average Number of Adults in Household Between IgG Antibody-positive vs. Negative Participants

    Time frame: Survey completed before or on day of serology testing asking about information from January 1, 2020 to May 5, 2020

    Secondary outcomes included differences in the survey responses between IgG antibody-positive and -negative participants. These included demographics such as number of adult household members.

  6. Differences in Comorbidities Between IgG Antibody-positive vs. Negative Participants

    Time frame: Survey completed before or on day of serology testing asking about information from January 1, 2020 to May 5, 2020

    Secondary outcomes included differences in the survey responses between IgG antibody-positive and -negative participants. These included comorbidities.

Other outcomes

  1. Participants Who Were Eligible for in Plasma Donation

    Time frame: Serology Test #1 (Study Enrollment) and Test #2 (3 months apart)

    Individuals who tested positive for COVID-19 who may be eligible for convalescent plasma donation

Sponsors and collaborators

Lead sponsor

Hospital for Special Surgery, New York

Other

Registry information

Official study title

Hospital for Special Surgery COVID-19 Antibody Serology Among Anesthesiologists and Surgeons 2020

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
May 15, 2020
Registry last updated
Jan 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.